Skip to main content

ORBIMED ADVISORS LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1055951 New York, NY

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$53,541,240
+$43,375,357 QoQ
Shares Held
2,042,000
+6.7% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#15
of 271 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 26% Shared 0% None 74%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. ARQT ranks #21 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ARQT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $53,541,240 2,042,000
2023-09-30 $10,165,883 1,914,479
2023-06-30 $18,244,984 1,914,479
2023-03-31 $21,059,269 1,914,479
2022-12-31 $36,409,598 2,460,108
2022-09-30 $53,508,000 2,800,000
2022-06-30 $101,896,876 4,781,646
2022-03-31 $116,982,351 6,073,850
2021-12-31 $125,971,649 6,073,850
2021-09-30 $145,104,276 6,073,850
2021-06-30 $165,755,366 6,073,850
2021-03-31 $175,716,480 6,073,850
2020-12-31 $170,857,400 6,073,850
2020-09-30 $136,943,805 4,673,850
2020-06-30 $141,337,224 4,673,850
2020-03-31 $139,280,730 4,673,850